A 10-year study has determined that annual CT scans could prevent as many as half of lung cancer deaths. Annual screening detects early-stage lung cancers, which have a curability rate of 80% to 90%.
A 10-year study has determined that annual CT scans could prevent as many as half of lung cancer deaths. Annual screening detects early-stage lung cancers, which have a curability rate of 80% to 90%.
"More than 80% of the diagnosed lung cancer we found in initial and annual repeat CT screenings were stage I, the most curable form of lung cancer," said Dr. Claudia I. Henschke, principal investigator and division chief of chest imaging at New York Hospital-Cornell Medical Center.
An international study of 2968 high-risk patients conducted by the Early Lung Cancer Action Project found that annual screens are most likely to catch lung cancer at its earliest stages. Lung cancer symptoms often do not appear until the cancer has advanced to stage II or III.
The ELCAP study found that people with part-solid lung nodules were 19 times more likely to develop cancer than those with completely solid nodules. In addition, at-risk women are 2.2 times more likely to develop cancer than at-risk men.
"There is, as of yet, no clear consensus why women are at increased risk," Henschke said.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.